Company intelligence / Profile preview

Iofina

Oklahoma, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Iofina is a global leader in the sustainable extraction of iodine and its chemical derivatives, supplying key markets including health, pharmaceuticals, biocides, and diagnostics. The company is consistently expanding capacity; revenue hit $54.5 million in 2024 and production reached record levels in 2025, with stable or increasing demand in health, pharmaceutical, and industrial sectors. Its products, including potassium iodide and iodine, are used directly in healthcare and as pharmaceutical ingredients. Iofina is not a drug developer, but a specialty chemical and ingredient supplier.

Therapeutic areas: Infectious DiseasesEndocrinologyOther
Modalities: Small moleculeInorganic compound
Industry: Chemicals & Materials

Partnerships

Oil and gas operators for brine sourcingSaltwater disposal operators for raw material supply

Beyond the preview

Go deeper on Iofina.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iofina.

Explore the full profile